Comerica Bank I Teos Therapeutics, Inc. Transaction History

Comerica Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 21, 2023	BUY	$10.95 - $14.6 $134,060 - $178,747	12,243 New	12,243 $134,000
Q4 2022 Jan 26, 2023	SELL	$17.77 - $21.6 $75,167 - $91,368	-4,230 Reduced 22.56%	14,520 $0
Q3 2022 Oct 28, 2022	BUY	$18.6 - $27.25 $28,179 - $41,283	1,515 Added 8.79%	18,750 $351,000
Q2 2022 Aug 02, 2022	BUY	$16.57 - $35.1 $6,545 - $13,864	395 Added 2.35%	17,235 $453,000
Q1 2022 Apr 27, 2022	BUY	$31.92 - $47.45 $537,532 - $799,058	16,840 New	16,840 $0

150

37M

1.63M

1.96M

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $263M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.